Showing results (641-650 of 682) with videos related to
Sort By:
Pageof 69
BMC Infectious Diseases|April 14, 2012
Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infectionJörg Schüpbach, Leslie R Bisset, Martin D Gebhardt, et al.Cancer Prevention Research (Philadelphia, Pa.)|November 8, 2017
Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal NeoplasiaDon A Delker, Austin C Wood, Angela K Snow, et al.Plos One|March 3, 2012
Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activationEmilie Zuercher, Christophe Butticaz, Josiane Wyniger, et al.Molecular Pharmaceutics|January 5, 2018
Evaluation of the Active Targeting of Melanin Granules after Intravenous Injection of Dendronized NanoparticlesC Bordeianu, A Parat, S Piant, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2011
[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cellsCathy C Zhang, Zhengming Yan, Wenlin Li, et al.Blood|November 3, 2009
A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivoKeguo Li, Yannick Blum, Anjali Verma, et al.Operative Neurosurgery (Hagerstown, Md.)|April 14, 2026
Application of Mixed Reality in Endoscopic Streaming During Skull Base SurgeryYujin Choi, Shovan Bhatia, Adam C Monek, et al.Antimicrobial Agents and Chemotherapy|November 21, 2018
Examination of Fluconazole-Induced Alopecia in an Animal Model and Human CohortGeorge R Thompson, Charles R Krois, Verena K Affolter, et al.Oncology Reports|February 2, 2012
Increased basic fibroblast growth factor release and proliferation in xenotransplanted squamous cell carcinoma after combined irradiation/anti-vascular endothelial growth factor treatmentKai Fruth, Stefan Weber, Yunus Okcu, et al.British Journal of Cancer|July 14, 2011
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studiesT Eisen, R Marais, A Affolter, et al.Pageof 69